DMK Pharmaceuticals files for chapter 11 bankruptcy, shares plunge premarket

seekingalpha
2024/02/05
  • DMK Pharmaceuticals (NASDAQ:DMK) and subsidiaries commenced bankruptcy cases by filing voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
  • The parties expect that the court will approve the relief sought in these motions on an interim basis, it said on Feb. 2.
  • DMK -20.90% premarket to $0.4113
  • Source: Press Release

More on DMK Pharmaceuticals

  • Seeking Alpha’s Quant Rating on DMK Pharmaceuticals
  • Historical earnings data for DMK Pharmaceuticals
  • Financial information for DMK Pharmaceuticals

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10